{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Episode 41 - Holley Miller and Why Better Science Isn't Enough in Pharma","description":"My guest in today's episode is Holley Miller. Holley is the Founder and President of Grey Matter Marketing, where she helps life sciences CEOs engineer adoption before they ever sell a product. She has spent nearly two decades working with pre-commercial and growth-stage companies across medtech, pharma, and digital health, and her clients\u2019 results include a J&amp;amp;J acquisition and over $4.5 billion in enterprise value. In this interview, Holley Miller shares insights on why great healthcare products often fail despite strong science, emphasizing the importance of belief, behavior change, and strategic market positioning in pharma. The discussion covers how to engineer market adoption, the role of belief in clinical and consumer decision-making, and future trends in pharma commercialization. Key topics:  Market adoption challenges in pharma The role of belief and behavior in healthcare decisions Strategies for successful product launch and scaling  Having spend most of my career in drug development, this discussion around commercial launch was very educating for me. I enjoyed it a lot. Hope you do too. Here's Holley Miller. ","author_name":"The Future of Pharma","author_url":"https:\/\/www.ispeboston.org\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/43394289\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/207930939"}